Perceived Risk Among Human Immunodeficiency Virus Serodiscordant Couples in East Africa Taking Oral Pre-Exposure Prophylaxis.

作者: Jennifer J. Carroll , Renee Heffron , Nelly Mugo , Kenneth Ngure , Patrick Ndase

DOI: 10.1097/OLQ.0000000000000472

关键词:

摘要: OBJECTIVES Perceived risk of human immunodeficiency virus (HIV) infection is thought to drive low adherence in pre-exposure prophylaxis (PrEP) trials. We explored the level perceived incident HIV Partners PrEP Study, which was generally high. METHODS A cross-sectional questionnaire assessed at 12 months after enrollment. Logistic regression used analyze relationship between and other demographic behavioral variables. RESULTS Three thousand two hundred twenty-six couples from Study were included this analysis. Only 15.4% participants reported high or moderate risk. Participants acquiring slightly more likely report (odds ratio, 1.60; 95% confidence interval, 1.30-1.95; P < 0.001); nevertheless, only 20% with high-risk CONCLUSIONS but adherent PrEP. Perceptions are socially determined complex than Likert scale questionnaires capture.

参考文章(19)
Tim Brown, AIDS, risk and social governance. Social Science & Medicine. ,vol. 50, pp. 1273- 1284 ,(2000) , 10.1016/S0277-9536(99)00370-6
Erin M. Kahle, James P. Hughes, Jairam R. Lingappa, Grace John-Stewart, Connie Celum, Edith Nakku-Joloba, Stella Njuguna, Nelly Mugo, Elizabeth Bukusi, Rachel Manongi, Jared M. Baeten, An empiric risk scoring tool for identifying high-risk heterosexual HIV-1 serodiscordant couples for targeted HIV-1 prevention Journal of Acquired Immune Deficiency Syndromes. ,vol. 62, pp. 339- 347 ,(2013) , 10.1097/QAI.0B013E31827E622D
Andreas B. Eisingerich, Ana Wheelock, Gabriela B. Gomez, Geoffrey P. Garnett, Mark R. Dybul, Peter K. Piot, Attitudes and Acceptance of Oral and Parenteral HIV Preexposure Prophylaxis among Potential User Groups: A Multinational Study PLoS ONE. ,vol. 7, pp. e28238- ,(2012) , 10.1371/JOURNAL.PONE.0028238
Jared M. Baeten, Jessica E. Haberer, Albert Y. Liu, Nirupama Sista, Preexposure prophylaxis for HIV prevention: where have we been and where are we going? Journal of Acquired Immune Deficiency Syndromes. ,vol. 63, ,(2013) , 10.1097/QAI.0B013E3182986F69
Kachit Choopanya, Michael Martin, Pravan Suntharasamai, Udomsak Sangkum, Philip A Mock, Manoj Leethochawalit, Sithisat Chiamwongpaet, Praphan Kitisin, Pitinan Natrujirote, Somyot Kittimunkong, Rutt Chuachoowong, Roman J Gvetadze, Janet M McNicholl, Lynn A Paxton, Marcel E Curlin, Craig W Hendrix, Suphak Vanichseni, None, Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial The Lancet. ,vol. 381, pp. 2083- 2090 ,(2013) , 10.1016/S0140-6736(13)61127-7
Nina Glick Schiller, Stephen Crystal, Denver Lewellen, Risky business: the cultural construction of AIDS risk groups. Social Science & Medicine. ,vol. 38, pp. 1337- 1346 ,(1994) , 10.1016/0277-9536(94)90272-0
Meg Gerrard, Frederick X. Gibbons, Brad J. Bushman, Relation Between Perceived Vulnerability to HIV and Precautionary Sexual Behavior Psychological Bulletin. ,vol. 119, pp. 390- 409 ,(1996) , 10.1037/0033-2909.119.3.390
Norma C. Ware, Monique A. Wyatt, Jessica E. Haberer, Jared M. Baeten, Alexander Kintu, Christina Psaros, Steven Safren, Elioda Tumwesigye, Connie L. Celum, David R. Bangsberg, What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. Journal of Acquired Immune Deficiency Syndromes. ,vol. 59, pp. 463- 468 ,(2012) , 10.1097/QAI.0B013E31824A060B
Jeanne M. Marrazzo, Gita Ramjee, Barbra A. Richardson, Kailazarid Gomez, Nyaradzo Mgodi, Gonasagrie Nair, Thesla Palanee, Clemensia Nakabiito, Ariane van der Straten, Lisa Noguchi, Craig W. Hendrix, James Y. Dai, Shayhana Ganesh, Baningi Mkhize, Marthinette Taljaard, Urvi M. Parikh, Jeanna Piper, Benoît Mâsse, Cynthia Grossman, James Rooney, Jill L. Schwartz, Heather Watts, Mark A. Marzinke, Sharon L. Hillier, Ian M. McGowan, Z. Mike Chirenje, Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women The New England Journal of Medicine. ,vol. 372, pp. 509- 518 ,(2015) , 10.1056/NEJMOA1402269
Amy Corneli, Meng Wang, Kawango Agot, Khatija Ahmed, Johan Lombaard, Lut Van Damme, FEM-PrEP Study Group, None, Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP. Journal of Acquired Immune Deficiency Syndromes. ,vol. 67, pp. 555- 563 ,(2014) , 10.1097/QAI.0000000000000362